Radioiodine-refractory Differentiated Thyroid Cancer
📧 Sign up to get email alerts when something new happens for Radioiodine-refractory Differentiated Thyroid Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Sacituzumab Tirumotecan Combined With Immunotherapy in Advanced Thyroid Cancer [NA]
A clinical trial update indicates recruitment for a study of Sacituzumab Govitecan in combination with immunotherapy for advanced thyroid ca…
-
CLINICAL_TRIALS research · 2025-04-15Clinical Trial Update: Study of 177Lu-LNC1004 Injection in FAP-positive Radioiodine-refractory Differentiated Thyroid Cancer [EARLY_Phase 1]
Early-phase clinical trial evaluating 177Lu-LNC1004 injection for FAP-positive, radioiodine-refractory differentiated thyroid cancer, curren…